SG46683A1 - Process for obtaining insulin having correctly linked cystine bridges - Google Patents

Process for obtaining insulin having correctly linked cystine bridges

Info

Publication number
SG46683A1
SG46683A1 SG1996008251A SG1996008251A SG46683A1 SG 46683 A1 SG46683 A1 SG 46683A1 SG 1996008251 A SG1996008251 A SG 1996008251A SG 1996008251 A SG1996008251 A SG 1996008251A SG 46683 A1 SG46683 A1 SG 46683A1
Authority
SG
Singapore
Prior art keywords
insulin
arg
peptide
lys
protein
Prior art date
Application number
SG1996008251A
Other languages
English (en)
Inventor
Rainer Obermeier
Martin Gerl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SG46683A1 publication Critical patent/SG46683A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996008251A 1994-02-18 1995-02-09 Process for obtaining insulin having correctly linked cystine bridges SG46683A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405179A DE4405179A1 (de) 1994-02-18 1994-02-18 Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
SG46683A1 true SG46683A1 (en) 1998-02-20

Family

ID=6510552

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008251A SG46683A1 (en) 1994-02-18 1995-02-09 Process for obtaining insulin having correctly linked cystine bridges

Country Status (15)

Country Link
US (1) US5663291A (fr)
EP (1) EP0668292B1 (fr)
JP (1) JP3863579B2 (fr)
KR (1) KR100371824B1 (fr)
AT (1) ATE166069T1 (fr)
AU (1) AU699817B2 (fr)
CA (1) CA2142780C (fr)
DE (2) DE4405179A1 (fr)
DK (1) DK0668292T3 (fr)
ES (1) ES2119241T3 (fr)
FI (1) FI115916B (fr)
HK (1) HK1010457A1 (fr)
IL (1) IL112680A0 (fr)
NO (1) NO318424B1 (fr)
SG (1) SG46683A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2218622T3 (es) 1996-07-26 2004-11-16 Aventis Pharma Deutschland Gmbh Derivados de insulina con actividad de union al zinc incrementada.
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19825447A1 (de) * 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
FI107115B (fi) * 1998-09-30 2001-06-15 Valio Oy Menetelmä naudan insuliinin poistamiseksi
ATE257514T1 (de) 1998-10-09 2004-01-15 Scil Proteins Gmbh Verfahren zur gewinnung von aktivem beta-ngf
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6746853B1 (en) 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
AU2002316807A1 (en) * 2001-06-08 2002-12-23 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
DE602004025192D1 (de) * 2003-12-05 2010-03-11 Roche Diagnostics Gmbh Rekombinante Carboxypeptidase B und ihre Aufreinigung
DE102004015965A1 (de) 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
CN102015762B (zh) * 2008-02-19 2015-03-18 百康有限公司 获得纯化的生物活性异源蛋白的方法
WO2009133529A2 (fr) * 2008-04-30 2009-11-05 Wockhardt Research Centre Procédés pour le repliement de l’insuline
PL219335B1 (pl) * 2008-07-04 2015-04-30 Inst Biotechnologii I Antybiotyków Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna
RS56632B1 (sr) 2008-10-17 2018-03-30 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
UA91281C2 (ru) * 2008-11-26 2010-07-12 Общество С Ограниченной Ответственностью «Мако» Способ получения рекомбинантного инсулина человека
AU2010317995B2 (en) 2009-11-13 2014-04-17 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
CN102711804B (zh) 2009-11-13 2015-09-16 赛诺菲-安万特德国有限公司 包含glp-1激动剂和甲硫氨酸的药物组合物
JP6199186B2 (ja) 2010-08-30 2017-09-20 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病の治療用の医薬の製造のためのａｖｅ００１０の使用
BR112013025151B1 (pt) 2011-04-01 2021-09-28 3M Innovative Properties Company Laminação retrorrefletiva
WO2012152439A1 (fr) * 2011-05-10 2012-11-15 Glucometrix Ag Système tampon complet pour la renaturation de la pro-insuline humaine ou de dérivés de pro-insuline humaine
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
JP6367115B2 (ja) 2011-08-29 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病患者の血糖コントロールに使用する組合せ医薬
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP2931301B2 (fr) 2012-12-17 2021-09-15 Merck Sharp & Dohme Corp. Procédé pour purifier l'insuline et ses analogues
US10407483B2 (en) 2014-03-14 2019-09-10 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
MX2017007699A (es) 2014-12-12 2017-09-18 Sanofi Aventis Deutschland Formulacion de proporcion fija de insulina glargina/lixisenatida.
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1154435A (fr) * 1980-03-27 1983-09-27 Bruce H. Frank Procede de production d'un precurseur de l'insuline
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
DE4012818A1 (de) * 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE58906966D1 (de) * 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
DE4028120C2 (de) * 1990-09-05 1996-09-19 Hoechst Ag Verfahren zur Reinigung von Insulin und/oder Insulinderivaten
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
EP0599303A3 (fr) * 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Conjugués peptidiques
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
US5523293A (en) * 1994-05-25 1996-06-04 Iowa State University Research Foundation, Inc. Soy protein-based thermoplastic composition for preparing molded articles

Also Published As

Publication number Publication date
FI950699A (fi) 1995-08-19
CA2142780A1 (fr) 1995-08-19
ATE166069T1 (de) 1998-05-15
DE4405179A1 (de) 1995-08-24
FI115916B (fi) 2005-08-15
AU1228895A (en) 1995-08-31
EP0668292B1 (fr) 1998-05-13
EP0668292A2 (fr) 1995-08-23
CA2142780C (fr) 2008-10-14
KR950032282A (ko) 1995-12-20
EP0668292A3 (fr) 1996-02-07
US5663291A (en) 1997-09-02
JPH07265092A (ja) 1995-10-17
JP3863579B2 (ja) 2006-12-27
NO318424B1 (no) 2005-04-18
FI950699A0 (fi) 1995-02-16
NO950592L (no) 1995-08-21
DK0668292T3 (da) 1998-11-23
NO950592D0 (no) 1995-02-17
KR100371824B1 (ko) 2003-04-10
DE59502138D1 (de) 1998-06-18
ES2119241T3 (es) 1998-10-01
AU699817B2 (en) 1998-12-17
IL112680A0 (en) 1995-05-26
HK1010457A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
SG46683A1 (en) Process for obtaining insulin having correctly linked cystine bridges
KR100537842B1 (ko) 정확하게 결합된 시스틴 브릿지를 갖는 인슐린 전구체를 수득하는 방법
PL315791A1 (en) Multivariant haemopoesive fusion protein il-3
DE69929805D1 (de) Modifiziertes e.coli enterotoxin ii signalpeptid sowie ein mikroorganismus der ein fusionsprotein sowie ein heterologes protein exprimiert
DE3485199D1 (fr)
ATE381619T1 (de) Verfahren zur herstellung von rekombinantem insulin durch fusionsproteine
NZ196609A (en) Preparation of proinsulin-like insulin precursors
Gattner et al. Enzyme-catalysed semi-synthesis with insulin derivatives
DE69428401T2 (de) Verfahren zur Herstellung von alpha-Aminosäureamiden zur Verwendung in der Peptidsynthese
Gattner et al. Trypsin catalyzed peptide synthesis: modification of the B-chain C-terminal region of insulin
Canova-Davis et al. Specific activation of the arginine carboxyl group of the B-chain of bovine des-octapeptide-(B23–30)-insulin
EP0959895A4 (fr) Peptides sensibles a des anticorps diriges contre un peptide consensus des proteines de la famille c54-cfa/i
MXPA98006666A (en) Improved procedure for the obtaining of insulin precursors with cistina bridges correctly uni